Alyeska Investment Group, L.P. Cor Medix Inc. Transaction History
Alyeska Investment Group, L.P.
- $25.4 Billion
- Q2 2025
A detailed history of Alyeska Investment Group, L.P. transactions in Cor Medix Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 750,000 shares of CRMD stock, worth $8.81 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
750,000Holding current value
$8.81 Million% of portfolio
0.04%Shares
2 transactions
Others Institutions Holding CRMD
# of Institutions
183Shares Held
32.8MCall Options Held
867KPut Options Held
561K-
Vanguard Group Inc Valley Forge, PA4.33MShares$50.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$41.7 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$30.3 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.71MShares$20.1 Million0.0% of portfolio
-
State Street Corp Boston, MA1.6MShares$18.8 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $484M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...